Bob G. Gower, Director at Ensysce Biosciences, Inc. (ENSC), bought 908,614 shares at $0.48 ($444K) on 2026-04-23, disclosed to the SEC on 2026-08-18.
Open-market purchase of $444k ENSC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.48 | 508,614 | $246K | 55.4% |
| 2 | $0.49 | 400,000 | $198K | 44.6% |
| Total | $0.49 avg | 908,614 | $444K | 100% |
| Filing → |
| ENSC | BUY | 2023-02-01 | $1.0M | — | Filing → |
| MILL | BUY | 2015-01-06 | $43K | — | Filing → |
| MILL | BUY | 2014-12-22 | $76K | — | Filing → |